McCormick & Co Inc Interim Filing: Six-Month Earnings Climb Higher While Quarterly Net Income Softens

Bottom line

MCCORMICK & CO INC (MKC) filed 10-Q for period-ended-2026-05-31 with the SEC under accession 0000063754-26-000274, CIK 0000063754. The filing presents both a three-month reporting period and a six-month year-to-date period, with prior-year comparatives alongside. The opening read is mixed: the top line moved higher on both windows, operating profit improved on both windows, but bottom-line profit expanded on the six-month window while contracting on the three-month window. Subsequent sections of this analysis will examine drivers, segment composition, and cash-flow posture in more detail.

For the three-month reporting period, Revenues were $1,936,600,000 against $1,659,500,000 in the prior-year window, an authorized revenue increase. Operating Income (Loss) on the same window was $276,400,000, versus $245,800,000 in the prior-year window, an authorized operating-income increase. Net Income (Loss) Attributable to Parent on the quarter was $150,100,000, compared with $175,000,000 in the prior-year window, an authorized net-income decrease, with both periods remaining profitable. Earnings Per Share, Diluted on the quarter was $0.56 per diluted share, against $0.65 per diluted share in the prior-year window, an authorized EPS decrease, with both periods remaining profitable.

For the six-month year-to-date period, Revenues were $3,810,500,000 against $3,265,000,000 in the prior-year window, an authorized revenue increase. Operating Income (Loss) for the half-year was $503,900,000, versus $471,000,000 in the prior-year window, an authorized operating-income increase. Net Income (Loss) Attributable to Parent for the six months was $1,166,300,000, against $337,300,000 in the prior-year window, an authorized net-income increase, with both periods profitable. Earnings Per Share, Diluted for the six months was $4.33 per diluted share, against $1.25 per diluted share in the prior-year window, an authorized EPS increase, with both periods profitable.

The filing evidence does not attribute this change to any single cause.

The filing evidence contains no peer or industry comparison.

Sources cited in this section are the consolidated statements within 10-Q for period-ended-2026-05-31, specifically the condensed consolidated income statement covering the three-month period and the six-month year-to-date period, with the comparable prior-year windows. Acquisition-related disclosures tied to Note 2 and segment-reporting adoption context in Note 11 also fall within the source scope of this filing. Financing-program detail in Note 4 is captured in the broader filing but is not a headline earnings item for this section.

Within source scope, management's own framing in the Basis of Presentation notes that prior period amounts were reclassified, with Income from unconsolidated operations now reflected within Net income attributable to noncontrolling interests. The same commentary describes a recurring seasonal pattern in which the first half historically runs lower than the second half, with U.S. consumer holiday purchasing cited by the issuer. The IEEPA-tariff recovery receivable, the related cost-of-goods-sold reduction, and the inventory carrying-value reduction appear in management commentary within the filing. The reader-facing treatment of those items belongs to later sections of this analysis; here, the open-window read is the six-month profit-and-loss expansion alongside a softer quarter, set against the reclassification and seasonality context the issuer itself disclosed.

Financial performance

The reporting picture drawn from the filing under 10-Q for MCCORMICK & CO INC (MKC, accession 0000063754-26-000274) shows a company that remains firmly profitable on every measured line, but with a clear divergence between the six-month window and the most recent quarter. Revenues for the three-month period the three months ended May 31, 2026 totaled $1,936,600,000 USD, higher than the $1,659,500,000 USD reported in the prior-year comparative window. Revenues for the six-month period the six months ended May 31, 2026 came in at $3,810,500,000 USD, also above the $3,265,000,000 USD recorded for the six months ended May 31, 2025. The top-line growth pattern is therefore consistent across both measurement windows, with the quarterly reading showing the smaller of the two year-over-year directional moves and the half-year window showing the more pronounced lift.

Below the revenue line, the operating engine held up on a half-year basis but softened on the latest quarter. Operating income for the six months ended May 31, 2026 was $503,900,000 USD, higher than the $471,000,000 USD recorded a year earlier, with the transition remaining profit to profit. Operating income for the three months ended May 31, 2026 was $276,400,000 USD, also higher than the $245,800,000 USD in the comparable prior period and likewise profit to profit. Net income attributable to the parent followed a similar split: for the six months ended May 31, 2026, the figure of $1,166,300,000 USD exceeds the $337,300,000 USD prior-year reading on a profit-to-profit basis, while for the three months ended May 31, 2026 the $150,100,000 USD result sits below the $175,000,000 USD of the year-ago quarter, again on a profit-to-profit basis. Reported facts, drawn directly from the consolidated statements, frame this divergence as the central signal of the filing.

Diluted earnings per share echo that same shape. For the six months ended May 31, 2026, diluted EPS of $4.33 per diluted share USD/SHARES sits above the $1.25 per diluted share USD/SHARES comparative, with both periods in profit. For the three months ended May 31, 2026, diluted EPS of $0.56 per diluted share USD/SHARES is lower than the $0.65 per diluted share USD/SHARES posted a year ago, once more on a profit-to-profit transition. The half-year improvement combined with a quarterly decline is the headline dynamic readers should anchor on, alongside the matching revenue and operating income contrasts.

Management's own framing of the period centers on three accounting matters rather than on operating drivers. The first is the IEEPA tariff recovery: following the cited Supreme Court ruling, the company recorded a receivable under the loss recovery accounting model, reduced cost of goods sold by an undisclosed amount tied to previously expensed tariffs, and trimmed the carrying value of inventory, while flagging that any refund may be delayed, reduced, or denied. The second is recent standard adoption: the new segment reporting and hedge accounting updates were adopted with no material impact on the consolidated statements, as described in the cited note covering the segment standard and the derivatives update. The third is the McCormick de Mexico transaction, funded from cash on hand and commercial paper, which moved the entity from equity-method to consolidated reporting and produced a remeasurement gain on the previously held interest, with the residual noncontrolling interest now reflected in net income attributable to noncontrolling interests and results folded into the consumer and flavor solutions segments.

Because no commentary in the filing ties the operating softness on the most recent quarter to a named cause, any causal narrative here would be unsupported: The filing evidence does not attribute this change to any single cause.. On peer benchmarking, The filing evidence contains no peer or industry comparison. applies, so no industry comparison is asserted in this section. No management forward guidance statement is reproduced as fact, since none is quoted in the filing evidence; guidance and expectations are flagged only as a structural label here. The comparison baselines carried into the rest of the analysis are therefore the six-month improvement and the quarter-on-quarter contraction in net income and diluted EPS, set against consistent revenue and operating-income growth, with the tariff recovery and consolidation items as the two accounting context flags.

Operating drivers and segments

- Reported revenue moved from $3,265,000,000 USD for the six months ended May 31, 2025 to $3,810,500,000 USD for the six months ended May 31, 2026, an authorized year-over-year increase on the half-year window. - Reported operating income moved from $471,000,000 USD to $503,900,000 USD over the same half-year comparison, an authorized increase with profit-to-profit continuity. - Reported revenue moved from $1,659,500,000 USD for the three months ended May 31, 2025 to $1,936,600,000 USD for the three months ended May 31, 2026, an authorized year-over-year increase on the three-month view. - Reported operating income moved from $245,800,000 USD to $276,400,000 USD over the same quarter comparison, an authorized increase with profit-to-profit continuity. - The filing points incremental segment-expense disclosures and the chief operating decision maker identification to Note 11, so segment-level revenue and operating-income splits are not surfaced in the quoted interim text and cannot be used here to decompose the consolidated moves.

- Management frames the interim results as non-indicative of the full year because U.S. consumer purchasing historically skews to the fourth quarter around Thanksgiving and Christmas, leaving the the six months ended May 31, 2026 print as a structurally weaker window. - McCormick de Mexico is described as fully consolidated from the date of the controlling-interest acquisition referenced in Note 2, folding any inorganic contribution into the reported revenue and operating-income lines rather than presenting it separately. - Management describes a discretionary tariff item: after the Supreme Court ruling on IEEPA tariffs, a refund receivable was recorded, cost of goods sold was reduced in the three months ended May 31, 2026 for IEEPA tariff expense previously recognized on inventory sold, and the carrying value of remaining inventory was lowered, with explicit language that refunds may still be delayed, reduced, or denied pending appeal. - Two recent standard adoptions are presented as immaterial: the segment-reporting update in Note 11 and the hedge-accounting improvements adopted prospectively from the start of the fiscal year. - Bridge financing capacity referenced in Note 4 is framed as part of the mergers-and-acquisitions toolkit rather than as a margin or volume driver in the period.

The filing evidence does not attribute this change to any single cause.

The filing evidence contains no peer or industry comparison.

Cash flow and capital

Reported facts The six-month year-to-date operating cash inflow stood at $430,700,000 USD for the six months ended May 31, 2026, higher than the prior-year comparative of $161,400,000 USD for the six months ended May 31, 2025. Investing activities were a use of cash in both windows, at -$805,100,000 USD for the six months ended May 31, 2026 against -$105,200,000 USD for the six months ended May 31, 2025. Financing activities swung from a use of cash of -$142,900,000 USD in the six months ended May 31, 2025 to a source of $602,700,000 USD in the six months ended May 31, 2026, consistent with the company's stated mix of cash on hand and commercial paper borrowings funding the McCormick de Mexico step-up, as referenced in Note 2 and Note 4. The balance sheet showed Cash and Cash Equivalents, at Carrying Value of $331,200,000 USD as of the balance sheet date of May 31, 2026, alongside Long-term Debt, Excluding Current Maturities of $3,597,400,000 USD on the same date. Capital expenditures (Payments to Acquire Property, Plant, and Equipment) ran at $75,200,000 USD for the six months ended May 31, 2026, lower than $85,400,000 USD for the six months ended May 31, 2025. Share repurchases (Payments for Repurchase of Common Stock) were $10,900,000 USD for the six months ended May 31, 2026, down from $26,500,000 USD in the prior-year window, while ordinary common-stock dividends rose to $257,900,000 USD from $241,500,000 USD.

Management explanations The narrative accompanying the filing links the financing swing to the McCormick de Mexico additional-ownership acquisition, stating the purchase of the additional ownership interest was funded through a combination of cash on hand and commercial paper borrowings. Management describes goodwill as the value associated with expected synergies, the acquired workforce, and future growth opportunities, and notes that the step-up in inventory will be recognized in cost of goods sold as the related inventory is sold. The Bridge Facility is described in Note 4, and the supplier finance program context is in Note 2; Note 11 addresses an accounting standard whose adoption the filing describes as not having a material impact on the consolidated financial statements.

Analyst inference The shift in financing cash flow direction, paired with a still-positive operating cash inflow, suggests the company absorbed acquisition funding while continuing to return capital. The combination of lower buybacks and higher ordinary dividends points toward a tilt toward dividend reliability rather than opportunistic repurchases in the period. The inventory step-up flagged in the narrative implies a temporary non-cash gross margin headwind as the acquired McCormick de Mexico stock turns, while long-term debt levels and the balance-sheet cash position frame the post-deal liquidity profile.

Counter-evidence and unknowns The filing evidence does not attribute this change to any single cause. as a stand-alone reason for the change in any single line item. The filing evidence does not disclose segment-level detail for this dimension. applies to segment-level cash flow allocation. The filing evidence contains no peer or industry comparison. for any cross-company comparison of capital deployment. The filing does not disclose the final allocation of consideration to acquired net assets, so the future amortization pattern tied to intangibles and goodwill remains provisional.

Peer and historical context

- Across the half-year window, every authorized direction in the catalog for MCCORMICK & CO INC under 10-Q points the same way: Revenues, Operating Income, Net Income attributable to parent, Operating Cash Flow, and Diluted EPS are each higher than the prior-year half. The half-year picture is internally consistent. - The single three-month read does not match that pattern. Revenues for the quarter are higher than the prior-year quarter and Operating Income for the quarter is higher than the prior-year quarter, yet Net Income attributable to parent is lower than the prior-year quarter and Diluted EPS is lower than the prior-year quarter. The top of the income statement is moving up while the bottom is moving down on the three-month comparison. - That divergence — operating-line expansion alongside a bottom-line contraction on the quarter, with no corresponding gap on the half year — is the central feature of this section. It suggests the three-month result absorbed something between operating income and net income that the half-year total has not been able to absorb in the same way, or that the prior-year quarter contained a tailwind not repeated this year. The filing, on its face, does not isolate which.

- The case against reading the quarter as a clean bottom-line miss is that the same filing discusses the McCormick de Mexico acquisition — including a purchase-accounting step-up recognized in cost of goods sold, remeasurement of a previously held equity interest, and transaction and integration costs — plus a pending Unilever Foods merger with its own accounting footprint, and a noncontrolling-interest valuation reference. Those items live below the operating line. - The filing also says pro forma net earnings, assuming the McCormick de Mexico acquisition had occurred earlier, would not be materially different from results reported for the three and six months. That statement undercuts any narrative that the acquisition is the size of the gap, but it does not eliminate the possibility, and the filing evidence contains no directly visible countervailing data point that pegs the size of any below-the-line item against the prior-year quarter. - The filing evidence does not attribute this change to any single cause.

In MCCORMICK & CO INC's peer set, the filing itself offers no comparable company line items, The filing evidence contains no peer or industry comparison.. The only historical comparisons available in this section's evidence are the prior-year columns on the same statements. Against the six months ended May 31, 2025, Revenues reported for the six months ended May 31, 2026 were higher, Operating Income higher, Net Income attributable to parent higher, Operating Cash Flow higher, and Diluted EPS higher; against the three months ended May 31, 2025, Revenues for the three months ended May 31, 2026 were higher and Operating Income higher, but Net Income attributable to parent was lower and Diluted EPS lower.

For $3,265,000,000 against $3,810,500,000, the operating-income gap is in the same direction — $503,900,000 higher than $471,000,000 — and the cash conversion gap lines up with that, $430,700,000 higher than $161,400,000. Net Income follows: $1,166,300,000 higher than $337,300,000. Over the quarter, the operating engine is also moving in the right direction — $1,936,600,000 higher than $1,659,500,000 and $276,400,000 higher than $245,800,000 — but the bottom line is not, with $150,100,000 lower than $175,000,000. The filing evidence does not attribute this change to any single cause.

Readers running similar interim reviews across other names — for example, the Lizely Finance Earnings Analysis — ANI Pharmaceuticals Interim Filing: Profit-to-Profit Growth on Both Windows — should treat this quarter-versus-half divergence in MCCORMICK & CO INC as its own case rather than as a benchmark, since The filing evidence contains no peer or industry comparison. prevents a like-for-like peer read from this evidence.

Scenario analysis

- In the base path, the reported figures imply a continuation of the franchise's recent momentum rather than a sharp inflection. MCCORMICK & CO INC (MKC) posted Net Income (Loss) Attributable to Parent of $1,166,300,000 for the six months ended May 31, 2026, above the prior-year $337,300,000 for the six months ended May 31, 2025, while the three-month comparison of $150,100,000 against $175,000,000 for the three months ended May 31, 2026 versus the three months ended May 31, 2025 came in lower year over year even though both periods remained profitable.

Revenues of $3,810,500,000 for the six months ended May 31, 2026 topped $3,265,000,000 for the six months ended May 31, 2025, and the three-month line of $1,936,600,000 for the three months ended May 31, 2026 also outpaced $1,659,500,000 for the three months ended May 31, 2025. The base case reads as profit-to-profit on both windows for revenue and for the year-to-date bottom line, with the single softer reading sitting at the quarterly net income line. The filing evidence does not attribute this change to any single cause.

- An upside scenario layers the announced Unilever Foods combination on top of that base. The filing frames the deal, supported by the cited Bridge Commitment Letter in Note 4, as creating a global flavor leader, with Unilever retaining a sizable equity stake in the combined entity and receiving a one-time cash payment at closing. In this scenario, revenue at the combined company would step up materially once the merger closes, and the year-to-date profitability already visible in the base path — $1,166,300,000 versus $337,300,000 and $3,810,500,000 versus $3,265,000,000 — would be supplemented by the larger platform.

Pending shareholder approval, antitrust clearance, and registration-statement effectiveness all remain milestones the upside hinges on, and the deal is structured to qualify as a Reverse Morris Trust transaction. The filing evidence does not attribute this change to any single cause. - The downside scenario reflects what the same disclosed documents also reveal.

The quarterly net income comparison of $150,100,000 versus $175,000,000 already points to softer three-month earnings, while the cited note on the supplier-finance program in Note 2, ongoing Special charges tied to fixed-cost actions, and the cited adoption update in Note 11 each add execution and integration overhead. The Unilever transaction itself is conditional on shareholder approval, antitrust clearance, and registration-statement effectiveness, so a delayed or blocked deal would leave the franchise operating on the standalone base trajectory rather than the augmented one.

, so the flavor-focused narrative here is read against the disclosed numbers rather than a benchmark set, though readers can situate the trend against adjacent reporting windows such as the Broadcom Posts Higher Revenue, Operating Income, and Diluted EPS Year-Over-Year in the reporting period Filing insight when sizing the magnitude of a profit-to-profit print.

Risks and what to watch

- Reported facts: For the three-month reporting period the three months ended May 31, 2026, MCCORMICK & CO INC posted Revenues of $1,936,600,000 USD against a prior-year comparative of $1,659,500,000 USD, while Net Income (Loss) Attributable to Parent was $150,100,000 USD versus $175,000,000 USD. For the six-month year-to-date period the six months ended May 31, 2026, Revenues reached $3,810,500,000 USD (prior comparative $3,265,000,000 USD) and Net Income (Loss) Attributable to Parent was $1,166,300,000 USD (prior comparative $337,300,000 USD).

The filing of 10-Q for period-ended-2026-05-31, accession 0000063754-26-000274 (CIK 0000063754, ticker MKC), is the only source for these values here. - Management explanations: The narrative around the pending Unilever Foods combination frames much of the period's strategic posture. Management describes a Reverse Morris Trust structure, a one-time cash payment to Unilever subject to adjustments, the issuance of voting and non-voting securities to Unilever and Unilever shareholders, and a Bridge Facility arranged with the Commitment Parties that can be reduced by Permanent Financing proceeds or certain asset sales.

Special charges are described as costs tied to fixed-cost reduction, simplification, and acquisition-related transaction and integration expenses. - Analyst inference: The prior-period direction conventions in the catalog are the only year-over-year statements permitted in this article. Under those authorized comparisons, Revenues moved higher than the prior period on both the three-month and six-month windows, Operating Income moved higher than the prior period on both windows, and Net Income (Loss) Attributable to Parent moved higher than the prior period on the six-month window but lower than the prior period on the three-month window.

Diluted EPS is reported higher than the prior period on the six-month window and lower than the prior period on the three-month window. Operating cash flow moved higher than the prior period on the six-month window, financing cash flow moved higher than the prior period (current positive versus prior negative), investing cash flow moved lower than the prior period (both negative), ordinary dividend payments moved higher than the prior period, share repurchases moved lower than the prior period, and capital expenditures moved lower than the prior period.

- Counter-evidence: The three-month earnings slip against the prior year is the clearest counterweight to the otherwise positive six-month trajectory and the higher year-to-date operating cash flow. The pending transaction also introduces unusual items — bridge commitments that can be reduced by Permanent Financing, contingent one-time cash to Unilever, and Special charges tied to transaction and integration activity — that can move reported earnings independently of underlying demand. - Unknowns: The filing evidence does not attribute this change to any single cause..

The filing also does not provide segment-level granularity here, so the reader cannot tell which product or geography carried the three-month net income softness. The filing evidence contains no peer or industry comparison. and The filing evidence does not disclose segment-level detail for this dimension..

The new revenue-recognition standard referenced in the cited note is described as not having a material impact on the consolidated financial statements, but its ongoing disclosure effects remain open. Supply-chain financing presentation is touched on in the cited note. - Metrics to watch next period: completion of the Unilever Foods transaction, the size and timing of any Permanent Financing, ongoing bridge utilization, the run-rate of Special charges and transaction-and-integration costs, the ordinary dividend pace against the higher prior-period baseline, share-repurchase activity against the lower prior-period baseline, and the trajectory of the three-month net income line so the next quarter can confirm whether the dip was a single-quarter effect or the start of a wider divergence.

Readers modelling interim filings can benchmark against Lizely Finance Earnings Analysis — UFP TECHNOLOGIES INC Interim Filing: Profit-to-Profit Growth on Both Windows.